These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35108710)

  • 1. Safe De-Labeling of Patients at Low Risk of Penicillin Allergy in Denmark.
    Fransson S; Boel JB; Mosbech HF; Poulsen LK; Ruff S; Garvey LH
    Int Arch Allergy Immunol; 2022; 183(6):640-650. PubMed ID: 35108710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy.
    Kuruvilla M; Shih J; Patel K; Scanlon N
    Allergy Asthma Proc; 2019 Jan; 40(1):57-61. PubMed ID: 30582497
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-step direct drug provocation testing is safe for delabelling selected non-low-risk penicillin allergy labels.
    Li J; Cvetanovski V; Fernando S
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):232-235. PubMed ID: 33865989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults.
    Brillant-Marquis F; Proulx É; Ratnarajah K; Lavoie A; Gauthier A; Gagnon R; Boursiquot JN; Verreault N; Marois L; Bédard MA; Boivin M; Bédard PM; Ouakki M; De Serres G; Drolet JP
    J Allergy Clin Immunol Pract; 2024 Feb; 12(2):451-457.e2. PubMed ID: 38572700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of incorrect penicillin allergy labels in a UK hospital.
    Hearsey D; Elkhalifa S; Sandoe J; Wilcock M; Owens R; Gay B; Wildblood C; Mendonca J; Leigh N; Powell N
    Clin Microbiol Infect; 2023 Oct; 29(10):1338.e1-1338.e4. PubMed ID: 37354996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies.
    Savic L; Thomas C; Fallaha D; Wilson M; Hopkins PM; Savic S; Clark SH;
    Br J Anaesth; 2020 Dec; 125(6):962-969. PubMed ID: 32859363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing.
    Marwood J; Aguirrebarrena G; Kerr S; Welch SA; Rimmer J
    Emerg Med Australas; 2017 Oct; 29(5):509-515. PubMed ID: 28378949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flucloxacillin Hypersensitivity: Patient Outcomes in a Multicenter Retrospective Study.
    Kennard L; Rutkowski K; Siew LQC; Nakonechna A; Sargur R; Egner W; Shrimpton A; Mirakian R; Wagner A
    J Allergy Clin Immunol Pract; 2019; 7(7):2212-2217.e1. PubMed ID: 30922988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation.
    Trautmann A; Brockow K; Behle V; Stoevesandt J
    J Allergy Clin Immunol Pract; 2019; 7(7):2218-2224. PubMed ID: 30980898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
    Lim PPC; Moore LN; Minich NM; Wessell KR; Desai AP
    Allergy Asthma Proc; 2024 Jan; 45(1):61-69. PubMed ID: 38151739
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral amoxicillin challenge for low-risk penicillin allergic patients.
    Livirya S; Pithie A; Chua I; Hamilton N; Doogue M; Isenman H
    Intern Med J; 2022 Feb; 52(2):295-300. PubMed ID: 32672891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population.
    Borch JE; Andersen KE; Bindslev-Jensen C
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):357-62. PubMed ID: 16623858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis.
    Casimir-Brown RS; Kennard L; Kayode OS; Siew LQC; Makris M; Tsilochristou O; Chytiroglou E; Nakonechna A; Rutkowski K; Mirakian R; Wagner A
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2001-2009. PubMed ID: 33444815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of a clinical pharmacist in spurious Penicillin allergy: a narrative review.
    Bhogal R; Hussain A; Balaji A; Bermingham WH; Marriott JF; Krishna MT
    Int J Clin Pharm; 2021 Jun; 43(3):461-475. PubMed ID: 33439428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal Testing Identifies 1 in 4 Patients with Nonimmediate Penicillin Allergy.
    Fransson S; Mosbech HF; Elberling J; Kappel M; Garvey LH
    Int Arch Allergy Immunol; 2021; 182(9):827-834. PubMed ID: 33873191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of skin testing and extended antibiotic courses in assessment of children with penicillin allergy: An Australian experience.
    Arnold A; Sommerfield A; Ramgolam A; Rueter K; Muthusamy S; Noble V; von Ungern-Sternberg BS; Lucas M
    J Paediatr Child Health; 2019 Apr; 55(4):428-432. PubMed ID: 30209846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Direct Challenge to Penicillin Skin Testing for the Outpatient Evaluation of Penicillin Allergy: A Randomized Controlled Trial.
    Mustafa SS; Conn K; Ramsey A
    J Allergy Clin Immunol Pract; 2019; 7(7):2163-2170. PubMed ID: 31170542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of de-labeling penicillin allergy.
    Stone CA; Trubiano J; Coleman DT; Rukasin CRF; Phillips EJ
    Allergy; 2020 Feb; 75(2):273-288. PubMed ID: 31049971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of Prolonged Provocation in Drug Allergy - Results From a Danish Allergy Clinic.
    Fransson S; Mosbech H; Kappel M; Hjortlund J; Poulsen LK; Kvisselgaard AD; Garvey LH
    J Allergy Clin Immunol Pract; 2017; 5(5):1394-1401. PubMed ID: 28454683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity.
    Confino-Cohen R; Rosman Y; Meir-Shafrir K; Stauber T; Lachover-Roth I; Hershko A; Goldberg A
    J Allergy Clin Immunol Pract; 2017; 5(3):669-675. PubMed ID: 28483317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.